BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35867724)

  • 21. Inhibitory Activities of Essential Oil Obtained from Turmeric and Its Constituents against β-Secretase.
    Matsumura S; Murata K; Zaima N; Yoshioka Y; Morimoto M; Kugo H; Yamamoto A; Moriyama T; Matsuda H
    Nat Prod Commun; 2016 Dec; 11(12):1785-1788. PubMed ID: 30508333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rotational constriction of curcuminoids impacts 5-lipoxygenase and mPGES-1 inhibition and evokes a lipid mediator class switch in macrophages.
    Rao Z; Caprioglio D; Gollowitzer A; Kretzer C; Imperio D; Collado JA; Waltl L; Lackner S; Appendino G; Muñoz E; Temml V; Werz O; Minassi A; Koeberle A
    Biochem Pharmacol; 2022 Sep; 203():115202. PubMed ID: 35932797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computational screening of potential anti-inflammatory leads from Jeevaneeya Rasayana plants targeting COX-2 and 5- LOX by molecular docking and dynamic simulation approaches.
    Hemavathi KN; Skariyachan S; Raju R; Keshava Prasad TS; Abhinand CS
    Comput Biol Med; 2024 Mar; 171():108164. PubMed ID: 38412690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A rat air pouch model for evaluating the efficacy and selectivity of 5-lipoxygenase inhibitors.
    Zweifel BS; Hardy MM; Anderson GD; Dufield DR; Pufahl RA; Masferrer JL
    Eur J Pharmacol; 2008 Apr; 584(1):166-74. PubMed ID: 18295198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New hybrid molecules combining benzothiophene or benzofuran with rhodanine as dual COX-1/2 and 5-LOX inhibitors: Synthesis, biological evaluation and docking study.
    El-Miligy MMM; Hazzaa AA; El-Messmary H; Nassra RA; El-Hawash SAM
    Bioorg Chem; 2017 Jun; 72():102-115. PubMed ID: 28390993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring N(1)-p-fluorobenzyl-cymserine as an inhibitor of 5-lipoxygenase as a candidate for type 2 diabetes and neurodegenerative disorder treatment.
    ul Ain Q; Greig NH; Nawaz MS; Rashid S; Kamal MA
    CNS Neurol Disord Drug Targets; 2014 Mar; 13(2):197-202. PubMed ID: 24059322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis and evaluation of 2-aryl quinoline derivatives against 12R-lipoxygenase (12R-LOX): Discovery of first inhibitor of 12R-LOX.
    Bhuktar H; Shukla S; Kakularam KR; Battu S; Srikanth M; Srivastava S; Medishetti R; Ram P; Jagadish PC; Rasool M; Chakraborty S; Khan N; Reddanna P; Oruganti S; Pal M
    Bioorg Chem; 2023 Sep; 138():106606. PubMed ID: 37210826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioassay-guided identification of an anti-inflammatory prenylated acylphloroglucinol from Melicope ptelefolia and molecular insights into its interaction with 5-lipoxygenase.
    Shaari K; Suppaiah V; Wai LK; Stanslas J; Tejo BA; Israf DA; Abas F; Ismail IS; Shuaib NH; Zareen S; Lajis NH
    Bioorg Med Chem; 2011 Nov; 19(21):6340-7. PubMed ID: 21958738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploration of binding site pattern in arachidonic acid metabolizing enzymes, Cyclooxygenases and Lipoxygenases.
    Reddy KK; Vidya Rajan VK; Gupta A; Aparoy P; Reddanna P
    BMC Res Notes; 2015 Apr; 8():152. PubMed ID: 25886468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ascorbic acid 6-palmitate: a potent inhibitor of human and soybean lipoxygenase-dependent lipid peroxidation.
    Mohamed R; Tarannum S; Yariswamy M; Vivek HK; Siddesha JM; Angaswamy N; Vishwanath BS
    J Pharm Pharmacol; 2014 Jun; 66(6):769-78. PubMed ID: 24359271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Docking, steered molecular dynamics, and QSAR studies as strategies for studying isoflavonoids as 5-, 12-, and 15-lipoxygenase inhibitors.
    Cabezas F; Mascayano C
    J Biomol Struct Dyn; 2019 Apr; 37(6):1511-1519. PubMed ID: 29624122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-inflammatory celastrol promotes a switch from leukotriene biosynthesis to formation of specialized pro-resolving lipid mediators.
    Pace S; Zhang K; Jordan PM; Bilancia R; Wang W; Börner F; Hofstetter RK; Potenza M; Kretzer C; Gerstmeier J; Fischer D; Lorkowski S; Gilbert NC; Newcomer ME; Rossi A; Chen X; Werz O
    Pharmacol Res; 2021 May; 167():105556. PubMed ID: 33812006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthetic curcuminoids modulate the arachidonic acid metabolism of human platelet 12-lipoxygenase and reduce sprout formation of human endothelial cells.
    Jankun J; Aleem AM; Malgorzewicz S; Szkudlarek M; Zavodszky MI; Dewitt DL; Feig M; Selman SH; Skrzypczak-Jankun E
    Mol Cancer Ther; 2006 May; 5(5):1371-82. PubMed ID: 16731771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The study of dual COX-2/5-LOX inhibitors by using electronic-topological approach based on data on the ligand-receptor interactions.
    Aksakal F; Shvets N; Dimoglo A
    J Mol Graph Model; 2015 Jul; 60():79-88. PubMed ID: 26117823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aloe emodin shows high affinity to active site and low affinity to two other sites to result consummately reduced inhibition of lipoxygenase.
    Sharanya CS; Arun KG; Sabu A; Haridas M
    Prostaglandins Other Lipid Mediat; 2020 Oct; 150():106453. PubMed ID: 32380176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A ligand-based comparative molecular field analysis (CoMFA) and homology model based molecular docking studies on 3', 4'-dihydroxyflavones as rat 5-lipoxygenase inhibitors: Design of new inhibitors.
    Ahamed TKS; Muraleedharan K
    Comput Biol Chem; 2017 Dec; 71():188-200. PubMed ID: 29112937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of polymethoxyflavones as potential cyclooxygenase-2 (COX-2), 5-lipoxygenase (5-LOX) and phosphodiesterase 4B (PDE4B) inhibitors.
    Md Idris MH; Mohd Amin SN; Mohd Amin SN; Wibowo A; Zakaria ZA; Shaameri Z; Hamzah AS; Selvaraj M; Teh LK; Salleh MZ
    J Recept Signal Transduct Res; 2022 Aug; 42(4):325-337. PubMed ID: 34323638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for natural inhibitors of 5-lipoxygenase from Zi-shen pill extract by affinity ultrafiltration coupled with ultra performance liquid chromatography-mass spectrometry.
    Wang S; Huai J; Shang Y; Xie L; Cao X; Liao J; Zhang T; Dai R
    J Ethnopharmacol; 2020 May; 254():112733. PubMed ID: 32145333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Designing therapeutically effective 5-lipoxygenase inhibitors.
    McMillan RM; Walker ER
    Trends Pharmacol Sci; 1992 Aug; 13(8):323-30. PubMed ID: 1413091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Homology modeling of 5-lipoxygenase and hints for better inhibitor design.
    Aparoy P; Reddy RN; Guruprasad L; Reddy MR; Reddanna P
    J Comput Aided Mol Des; 2008 Sep; 22(9):611-9. PubMed ID: 18231862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.